Loading...
XSTOKDEV
Market cap24mUSD
Dec 23, Last price  
0.99SEK
1D
-1.68%
1Q
-19.27%
Jan 2017
-83.45%
IPO
-97.48%
Name

Karolinska Development AB

Chart & Performance

D1W1MN
XSTO:KDEV chart
P/E
49.28
P/S
131.78
EPS
0.02
Div Yield, %
0.00%
Shrs. gr., 5y
30.09%
Rev. gr., 5y
-8.10%
Revenues
2m
-12.43%
2,322,00030,320,00013,895,00010,479,0009,943,0009,940,0005,030,0002,942,0005,360,0002,464,0003,073,0003,384,0002,651,0002,170,0002,300,0002,014,000
Net income
5m
P
-5,767,000-2,641,000-334,584,000-385,673,000-212,852,000197,163,000-375,815,000-1,054,673,000-216,832,000179,595,00030,510,000657,709,000-385,476,000353,847,000-145,038,0005,386,000
CFO
-25m
L-23.09%
-18,005,000-34,165,000-97,324,000-133,437,000-152,645,000-82,027,000-108,387,000-325,023,000-8,994,00011,331,00013,154,000-7,409,000-33,200,00016,701,000-32,534,000-25,021,000
Earnings
Feb 14, 2025

Profile

Karolinska Development AB (publ) is a venture capital firm specializing in investments in growth capital, seed stage, and early stage companies. It seeks to invest in pharmaceutical research and development, medical research, healthcare technology, gene research and development, drug delivery technologies, biotechnology, and life science tools and service sectors. The firm seeks to invest in the Nordic region with a focus on Sweden, Iceland, Norway, Finland, and Denmark. It prefers to be a lead investor in its portfolio companies however does consider co-investments also. It seeks to invest in up to five projects annually. Karolinska Development AB (publ) was founded in 2003 and is headquartered in Stockholm, Sweden.
URL
https://www.karolinskadevelopment.com/
IPO date
Apr 15, 2011
Employees
8
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
2,014
-12.43%
2,300
5.99%
2,170
-18.14%
Cost of revenue
1
Unusual Expense (Income)
NOPBT
2,014
2,300
2,170
NOPBT Margin
100.00%
100.00%
100.00%
Operating Taxes
56,916
(183,028)
Tax Rate
2,474.61%
NOPAT
2,014
(54,616)
185,198
Net income
5,386
-103.71%
(145,038)
-140.99%
353,847
-191.79%
Dividends
Dividend yield
Proceeds from repurchase of equity
254,911
BB yield
-57.24%
Debt
Debt current
3,070
753
125,335
Long-term debt
3,070
753
732
Deferred revenue
11,569
10,208
138,189
Other long-term liabilities
(11,569)
(9,016)
(113,232)
Net debt
(1,179,530)
(1,173,104)
(866,501)
Cash flow
Cash from operating activities
(25,021)
(32,534)
16,701
CAPEX
(6,422)
Cash from investing activities
(19,982)
(113,808)
(49,458)
Cash from financing activities
(803)
235,022
(714)
FCF
(5,395)
(67,470)
198,052
Balance
Cash
85,272
205,790
92,403
Long term investments
1,100,398
968,820
900,165
Excess cash
1,185,569
1,174,495
992,460
Stockholders' equity
(1,489,079)
(1,683,532)
(1,386,458)
Invested Capital
2,738,973
2,924,374
2,481,714
ROIC
0.07%
7.50%
ROCE
0.16%
0.19%
0.20%
EV
Common stock shares outstanding
269,833
257,417
198,095
Price
1.70
-1.73%
1.73
-67.48%
5.32
195.56%
Market cap
458,717
3.01%
445,332
-57.74%
1,053,868
195.56%
EV
(720,813)
(916,839)
208,196
EBITDA
2,812
2,990
2,860
EV/EBITDA
72.80
Interest
844
6,284
Interest/NOPBT
36.70%
289.59%